3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A guide to accelerated insulin degludec (Tresiba) titration: starting doses, step-up schedules, safety thresholds, and what the FDA label versus clinical judgment each support.
Evidence-based strategies for managing a Tresiba (insulin degludec) efficacy plateau, including dose escalation protocols, timing adjustments, and add-on therapy options backed by clinical trial data.
Evidence-based guide to slow titration of Tresiba (insulin degludec) for insulin-sensitive patients. Covers dose escalation protocols, clinical trial data, and real-world monitoring strategies.